Bio-Rad Laboratories (BIO) Cash & Equivalents (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Cash & Equivalents of $507.2 million for Q1 2026, down 2.72% year-over-year from $521.4 million in Q1 2025, and down 4.27% quarter-over-quarter from $529.8 million in Q4 2025.
Bio-Rad Laboratories (BIO) Cash & Equivalents (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Cash & Equivalents for 18 consecutive years, with $507.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 2.72% year-over-year to $507.2 million; the TTM figure through Mar 2026 stood at $507.2 million (down 2.72% YoY), while the FY2025 annual figure was $529.8 million, up 8.54% from the prior year.
- Cash & Equivalents declined to $507.2 million in Q1 2026 per BIO's latest filing, from $529.8 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $802.3 million in Q1 2022 and bottomed at $369.3 million in Q2 2025.
- Historically, Cash & Equivalents has averaged $478.2 million across 5 years, with a median of $457.8 million in 2023.
- Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 42.15% — and 2024, when it gained 20.88%.
- Bio-Rad Laboratories' Cash & Equivalents stood at $434.2 million in 2022, then retreated by 7.0% to $403.8 million in 2023, then rose by 20.88% to $488.1 million in 2024, then rose by 8.54% to $529.8 million in 2025, then dropped by 4.27% to $507.2 million in 2026.
- Business Quant data shows BIO's Cash & Equivalents at $507.2 million in Q1 2026, $529.8 million in Q4 2025, and $395.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.49 Bn | 345.80 Mn | 517.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 517.00 Mn |
| Mar 31, 2026 | 507.20 Mn |
| Dec 31, 2025 | 529.80 Mn |
| Sep 30, 2025 | 395.80 Mn |
| Jun 30, 2025 | 369.30 Mn |
| Mar 31, 2025 | 521.40 Mn |
| Dec 31, 2024 | 488.10 Mn |
| Sep 30, 2024 | 410.40 Mn |
| Jun 30, 2024 | 406.90 Mn |
| Mar 31, 2024 | 433.30 Mn |
| Dec 31, 2023 | 403.80 Mn |
| Sep 30, 2023 | 457.85 Mn |
| Jun 30, 2023 | 390.00 Mn |
| Mar 31, 2023 | 464.14 Mn |
| Dec 31, 2022 | 434.20 Mn |
| Sep 30, 2022 | 517.94 Mn |
| Jun 30, 2022 | 596.58 Mn |
| Mar 31, 2022 | 802.32 Mn |
| Dec 31, 2021 | 470.78 Mn |
| Sep 30, 2021 | 859.90 Mn |